Skip to content
  1. Home
  2. Fitness & muscle
  3. Hexarelin

Fitness & muscle

Hexarelin

Potent dual-receptor GH secretagogue with cardioprotective properties, limited by rapid receptor desensitization.

Research compound Fitness & muscle Anti-aging Recovery & healing

Reviewed 2026-09-12
Full name
Growth hormone secretagogue hexarelin
Also known as
Rix-002
Regulatory status
Research compound | Experimental cardiovascular use

Origin

Synthetic hexapeptide GH secretagogue that also binds CD36 receptors on cardiac and endothelial cells, unlike GHRP-2/6 which target GHSR1a primarily. More chemically stable than natural ghrelin.

Mechanism

GHSR1a agonism drives pituitary GH release; CD36 binding on cardiomyocytes triggers cardioprotective signaling via IL-1Ra upregulation and reduced myocardial oxidative stress during ischemia-reperfusion.

Research summary

Evidence

Protects rat cardiomyocytes from ischemia-reperfusion injury via IL-1 signaling. Multiple rodent studies document cardioprotection. Major limitation: rapid tachyphylaxis, meaning GH response and possibly cardioprotection diminish sharply with repeated dosing. Clinical translation is limited.

Evidence tier: Research compound — see the methodology note for how this is assessed.

Citations

Reported benefits

  • growth hormone stimulation
  • cardioprotection (animal evidence)
  • anti-inflammatory effects (theoretical)

Dosing protocols reported in the literature & community

These are protocols reported by compounding pharmacies, published trials, or self-experimentation communities — not a prescription. Start low, especially for anything new.

Reported dosing protocols
RouteReported protocol
Subcutaneous injection100-200 mcg 1-3x daily; cycling protocols (e.g. 5 days on/2 off) used to manage tachyphylaxis.

Side effects

  • appetite stimulation (mild-moderate)
  • cortisol elevation
  • prolactin elevation
  • rapid tolerance development (tachyphylaxis)

Safety notes

Safety: Not FDA-approved. Primary concern is rapid receptor desensitization limiting utility. Cardioprotective effects are documented only in acute animal models; no human long-term outcome data.
Community & reddit notes (anecdotal — not clinical evidence)

Adoption limited by tachyphylaxis. Some cycle or pulse-dose to maintain responsiveness; theoretical cardioprotective appeal in longevity circles.

Mixing compatibility

Pulled from a community-charted mixing-compatibility reference (anecdotal, clinic-use, and community-reported signals) — not a safety guarantee. Verify independently before combining anything.

Used together in wellness-clinic protocols

Reported as a combination to avoid